SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000364
Filing Date
2024-03-29
Accepted
2024-03-29 16:16:33
Documents
93
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fwbi-20231231x10k.htm   iXBRL 10-K 2930642
2 EX-4.31 fwbi-20231231xex4d31.htm EX-4.31 44929
3 EX-10.53 fwbi-20231231xex10d53.htm EX-10.53 221657
4 EX-14.1 fwbi-20231231xex14d1.htm EX-14.1 28484
5 EX-19.1 fwbi-20231231xex19d1.htm EX-19.1 51601
6 EX-21.1 fwbi-20231231xex21d1.htm EX-21.1 1457
7 EX-23.1 fwbi-20231231xex23d1.htm EX-23.1 3037
8 EX-31.1 fwbi-20231231xex31d1.htm EX-31.1 10520
9 EX-31.2 fwbi-20231231xex31d2.htm EX-31.2 12338
10 EX-32.1 fwbi-20231231xex32d1.htm EX-32.1 10989
11 EX-97.1 fwbi-20231231xex97d1.htm EX-97.1 38791
12 GRAPHIC fwbi-20231231xex14d1001.jpg GRAPHIC 16950
13 GRAPHIC fwbi-20231231xex19d1001.jpg GRAPHIC 12506
14 GRAPHIC fwbi-20231231xex97d1001.jpg GRAPHIC 12619
  Complete submission text file 0001410578-24-000364.txt   11222454

Data Files

Seq Description Document Type Size
15 EX-101.SCH fwbi-20231231.xsd EX-101.SCH 87532
16 EX-101.CAL fwbi-20231231_cal.xml EX-101.CAL 56421
17 EX-101.DEF fwbi-20231231_def.xml EX-101.DEF 329367
18 EX-101.LAB fwbi-20231231_lab.xml EX-101.LAB 707818
19 EX-101.PRE fwbi-20231231_pre.xml EX-101.PRE 523337
97 EXTRACTED XBRL INSTANCE DOCUMENT fwbi-20231231x10k_htm.xml XML 1423615
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37853 | Film No.: 24804301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)